BURKHARD BLANK
CIK 1073409 · EVP Chief Medical Officer · last filed 2025-07-17
BURKHARD BLANK is an EVP Chief Medical Officer who has filed 25 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $36.8K of MNKD on Jul 17, 2025. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.69M
3
25
-$1.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | EVP Chief Medical Officer | 460,791 | $3.66 | $1.69M | $0 | 7 | 2025-07-17 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | CMO and Head of R&D | 18,527 | $0.66 | $12.2K | -$1.33M | 14 | 2021-03-05 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | EVP & Chief Medical Officer | — | $10.12 | — | $0 | 4 | 2008-05-27 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-17 | MNKD | Tax (F) | −9,556 | -$36.8K | EDGAR |
| 2025-05-27 | MNKD | — | — | $0 | EDGAR |
| 2025-05-27 | MNKD | Tax (F) | −15,630 | -$64.4K | EDGAR |
| 2024-05-29 | MNKD | Tax (F) | −16,151 | -$77.2K | EDGAR |
| 2024-05-17 | MNKD | Grant (A) | +129,000 | $0 | EDGAR |
| 2024-02-05 | MNKD | Grant (A) | +157,905 | $515.4K | EDGAR |
| 2023-05-26 | MNKD | Grant (A) | +210,000 | $0 | EDGAR |
| 2021-03-05 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +11,125 | $0 | EDGAR |
| 2020-09-21 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +3,015 | $0 | EDGAR |
| 2019-11-12 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |